Redox-Responsive Porphyrin-Based Polysilsesquioxane Nanoparticles for Photodynamic Therapy of Cancer Cells

Int J Mol Sci. 2015 Dec 31;17(1):56. doi: 10.3390/ijms17010056.

Abstract

The development of stimulus-responsive photosensitizer delivery systems that carry a high payload of photosensitizers is of great importance in photodynamic therapy. In this study, redox-responsive polysilsesquioxane nanoparticles (PSilQNPs) built by a reverse microemulsion approach using 5,10,15,20-tetrakis(carboxyphenyl) porphyrin (TCPP) silane derivatives as building blocks, were successfully fabricated. The structural properties of TCPP-PSilQNPs were characterized by dynamic light scattering (DLS)/ζ-potential, scanning electron microscopy (SEM) and thermogravimetric analysis (TGA). The photophysical properties were determined by UV-vis and fluorescence spectroscopy. The quantity of singlet oxygen generated in solution was measured using 1,3-diphenylisobenzofuran. The redox-responsive release of TCPP molecules was successfully demonstrated in solution in the presence of a reducing agent. The internalization of TCPP-PSilQNPs in cancer cells was investigated using laser scanning confocal microscopy. Phototoxicity experiments in vitro showed that the redox-responsive TCPP-PSilQNPs exhibited an improved phototherapeutic effect on cervical cancer cells compared to a non-responsive TCPP-PSilQNP control material.

Keywords: cancer therapy; photodynamic therapy; photosensitizer delivery; polysilsesquioxane nanoparticles; porphyrin; stimulus-responsive materials.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Delayed-Action Preparations / chemistry*
  • HeLa Cells
  • Humans
  • Metalloporphyrins / administration & dosage*
  • Metalloporphyrins / pharmacokinetics
  • Metalloporphyrins / therapeutic use
  • Nanoparticles / chemistry*
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Organosilicon Compounds / chemistry*
  • Oxidation-Reduction
  • Photochemotherapy
  • Photosensitizing Agents / administration & dosage*
  • Photosensitizing Agents / pharmacokinetics
  • Photosensitizing Agents / therapeutic use

Substances

  • 5,10,15,20-tetrakis(4-carboxyphenyl)porphyrin cobalt
  • Delayed-Action Preparations
  • Metalloporphyrins
  • Organosilicon Compounds
  • Photosensitizing Agents
  • polysilsesquioxane